MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2033.53%
Quick Ratio
2033.53%
Cash Ratio
691.45%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
36,626 35,021 32,496 42,327
Short-term marketable securities
67,913 78,103 84,197 83,080
Prepaid expenses and other current assets
3,177 3,280 2,787 1,789
Total current assets
107,716 116,404 119,480 127,196
Long-term marketable securities
NaN 0 8,806 10,059
Operating lease right-of-use assets
39 78 115 152
Total assets
107,755 116,482 128,401 137,407
Accounts payable
2,303 1,309 4,243 1,921
Accrued expenses and other current liabilities
2,955 3,714 4,788 5,174
Operating lease liabilities
39 78 115 152
Total current liabilities
5,297 5,101 9,146 7,247
Common stock-Common Class A
3 3 3 3
Common stock-Common Class B
0 0 0 0
Additional paid-in capital
459,446 457,607 455,916 453,954
Accumulated deficit
-356,999 -346,349 -336,781 -323,873
Accumulated other comprehensive income
8 120 117 76
Total stockholders' equity
102,458 111,381 119,255 130,160
Total liabilities and stockholders' equity
107,755 116,482 128,401 137,407
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$67,913K Cash and cashequivalents$36,626K Prepaid expenses andother current assets$3,177K Total current assets$107,716K Operating leaseright-of-use assets$39K Total assets$107,755K Total liabilities andstockholders' equity$107,755K Total stockholders'equity$102,458K Total currentliabilities$5,297K Accumulated deficit-$356,999K Additional paid-in capital$459,446K Accrued expenses andother current...$2,955K Accounts payable$2,303K Operating leaseliabilities$39K Accumulated othercomprehensive income$8K Common stock-CommonClass A$3K

Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT)